ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

NCI Restructures AIDS Effort; New Research Thrusts Recommended

October 5, 1984

Abstracts Of Papers Presented By Breast Cancer Task Force

July 16, 1976

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980

Two “optimists” present different visions for rapid progress in cancer research at American Association for Cancer Research annual meeting. Leland Hartwell advocates genome-like project for molecular diagnostics. Andrew von Eschenbach describes “fantasies, dreams, visions” becoming reality.

April 9, 2004

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002